Sign In

Login

Password

Forgot Password ? Sign Up

Colestipolo (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Colestipolo" in Italian language version.

refsWebsite
Global rank Italian rank
18nih.gov
4th place
9th place
2oadoi.org
799th place
22nd place
2doi.org
2nd place
7th place

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • TM. Parkinson, K. Gundersen; NA. Nelson, Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man., in Atherosclerosis, vol. 11, n. 3, pp. 531-7, PMID 5433090.
  • TM. Parkinson, JC. Schneider; WA. Phillips, Effects of colestipol hydrochloride (U-26,597A) on serum and fecal lipids in dogs., in Atherosclerosis, vol. 17, n. 2, pp. 167-79, PMID 4709118.
  • DS. Goodman, RP. Noble; RB. Dell, The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man., in J Clin Invest, vol. 52, n. 10, Ott 1973, pp. 2646-55, DOI:10.1172/JCI107457, PMID 4729058.
  • HD. Webster, JA. Bollert, Toxicologic, reproductive and teratologic studies of colestipol hydrochloride, a new bile acid sequestrant., in Toxicol Appl Pharmacol, vol. 28, n. 1, Apr 1974, pp. 57-65, PMID 4855231.
  • RC. Heel, RN. Brogden; GE. Pakes; TM. Speight; GS. Avery, Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia., in Drugs, vol. 19, n. 3, Mar 1980, pp. 161-80, PMID 6988203.
  • J. LaRosa, Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels., in Cardiology, 76 Suppl 1, 1989, pp. 55-61; discussion 61-4, PMID 2653624.
  • DR. Illingworth, BE. Phillipson; JH. Rapp; WE. Connor, Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia., in Lancet, vol. 1, n. 8215, Feb 1981, pp. 296-8, PMID 6109940.
  • JP. Kane, MJ. Malloy; P. Tun; NR. Phillips; DD. Freedman; ML. Williams; JS. Rowe; RJ. Havel, Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen., in N Engl J Med, vol. 304, n. 5, Gen 1981, pp. 251-8, DOI:10.1056/NEJM198101293040502, PMID 7003391.
  • CJ. Glueck, Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis., in Ann Intern Med, vol. 96, n. 4, Apr 1982, pp. 475-82, PMID 7039445.
  • SM. Sirmans, JK. Beck; HL. Banh; DA. Freeman, Colestipol-induced hepatotoxicity., in Pharmacotherapy, vol. 21, n. 4, Apr 2001, pp. 513-6, PMID 11310528.
  • L. Cashin-Hemphill, CA. Spencer; JT. Nicoloff; DH. Blankenhorn; SA. Nessim; HP. Chin; NA. Lee, Alterations in serum thyroid hormonal indices with colestipol-niacin therapy., in Ann Intern Med, vol. 107, n. 3, Set 1987, pp. 324-9, PMID 3113309.
  • DM. Hibbard, JR. Peters; DB. Hunninghake, Effects of cholestyramine and colestipol on the plasma concentrations of propranolol., in Br J Clin Pharmacol, vol. 18, n. 3, Set 1984, pp. 337-42, PMID 6487473.
  • DB. Hunninghake, S. King; K. LaCroix, The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide., in Int J Clin Pharmacol Ther Toxicol, vol. 20, n. 4, Apr 1982, pp. 151-4, PMID 7076343.
  • SR. al-Balla, YM. el-Sayed; MA. al-Meshal; MW. Gouda, The effects of cholestyramine and colestipol on the absorption of diclofenac in man., in Int J Clin Pharmacol Ther, vol. 32, n. 8, Ago 1994, pp. 441-5, PMID 7981930.
  • JT. Callaghan, M. Tsuru; JL. Holtzman; DB. Hunninghake, Effect of cholestyramine and colestipol on the absorption of phenytoin., in Eur J Clin Pharmacol, vol. 24, n. 5, 1983, pp. 675-8, PMID 6873150.
  • PJ. Neuvonen, K. Kivistö; EL. Hirvisalo, Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide., in Br J Clin Pharmacol, vol. 25, n. 2, Feb 1988, pp. 229-33, PMID 3358884.
  • KE. Wirth, [Drug interactions in the use of cardiac glycosides]., in Med Welt, vol. 32, n. 7, Feb 1981, pp. 234-8, PMID 7010063.
  • LC. Knodel, RL. Talbert, Adverse effects of hypolipidaemic drugs., in Med Toxicol, vol. 2, n. 1, pp. 10-32, PMID 3547004.

oadoi.org